We provide you with 20 years of free, institutional-grade data for ACRS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACRS. Explore the full financial landscape of ACRS stock.
| Reported Date | CIK | Ticker | Type |
|---|
Aclaris Therapeutics, Inc(NASDAQ:ACRS) 
Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational or...
Website: http://www.aclaristx.com
Founded: 2012
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ACRS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.